Wilson T W, Jeffers J B, Nelson L B
Cataract and Primary Eye Care, Wills Eye Hospital, Philadelphia, Pa 19107.
Ophthalmic Surg. 1990 Nov;21(11):807-9.
Oral aminocaproic acid has been shown to be effective in clot stabilization and in the reduction of secondary bleeding rates in cases of traumatic hyphema. In a retrospective study of 105 patients treated during a 1-year period, we found the incidence of rebleeding in patients with traumatic hyphema who received aminocaproic acid prophylaxis was 2%; the incidence in those who did not was 25%.
口服氨基己酸已被证明在创伤性前房积血病例中对稳定血凝块和降低继发性出血率有效。在一项对1年内治疗的105例患者的回顾性研究中,我们发现接受氨基己酸预防的创伤性前房积血患者的再出血发生率为2%;未接受预防的患者再出血发生率为25%。